Subcutaneous drug delivery: An evolving enterprise-Reference-Cited by-同舟云学术

Subcutaneous drug delivery: An evolving enterprise

Published:2017-08-30 Issue:405 Volume:9 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Jones Graham B.¹^ORCID,Collins David S.²^ORCID,Harrison Michael W.²^ORCID,Thyagarajapuram Nagarajan R.²,Wright Justin M.²^ORCID

Affiliation:

1. Clinical and Translational Science Institute, Tufts University Medical Center, Boston, MA 02111, USA.

2. Eli Lilly Innovation Center, Cambridge, MA 02142, USA.

Abstract

Recent advances in subcutaneous drug delivery and device design are transforming the biopharmaceutical sector and improving patient care.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference10 articles.

1. Evaluating the administration costs of biologic drugs: Development of a cost algorithm;Tetteh E. K.;Health Econ. Rev.,2014

2. The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection;Jin J. F.;Patient Prefer. Adherence,2015

3. From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity

4. Anatomical, physiological, and experimental factors affecting the bioavailability of sc-administered large biotherapeutics;Fathallah A. M.;J. Pharm. Sci.,2015

5. Recombinant human hyaluronidase (rHuPH20) facilitates subcutaneous infusion of immunoglobulin, increases local fluid dispersion, and reduces induration in a porcine model;Kang D. W.;J. Allergy Clin. Immunol.,2012

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal profiling of biostabilized human skin modules reveals a coordinated ecosystem response to injected mRNA‐1273 COVID‐19 vaccine;Allergy;2024-08-19

2. Biorelevant subcutaneous in vitro test predicts the release of human and fast acting insulin formulations;International Journal of Pharmaceutics;2024-04

3. Subcutaneous drug delivery from nanoscale systems;Nature Reviews Bioengineering;2024-03-19

4. Clinical Investigation of Large Volume Subcutaneous Delivery up to 25 mL for Lean and Non-Lean Subjects;Pharmaceutical Research;2024-03-05

5. DNA tetrahedral nanostructures for the biomedical application and spatial orientation of biomolecules;Bioactive Materials;2024-03